Premium
EXCELLENT OUTCOMES USING RITUXIMAB, GEMCITABINE, CYCLOPHOSPHAMIDE, VINCRISTINE, PREDNISOLONE (R‐GCVP) IN PATIENTS WITH DLBCL AND CARDIAC COMORBIDITIES
Author(s) -
Michalarea V.,
Low R.,
Kirkwood A.A.,
Harrington P.,
Yadollahi S.,
Djebbari F.,
Gleeson M.,
Cwynarski K.,
Lambert J.,
Chau I.,
Wrench D.,
Eyre T.A.,
Davies A.,
Ardeshna K.M.,
Cunningham D.,
Fields P.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.97_2631
Subject(s) - medicine , ejection fraction , international prognostic index , vincristine , regimen , anthracycline , rituximab , diffuse large b cell lymphoma , prednisolone , oncology , gemcitabine , interquartile range , cyclophosphamide , surgery , cardiology , lymphoma , heart failure , cancer , chemotherapy , breast cancer